Synribo Prices, Coupons and Patient Assistance Programs
Synribo (omacetaxine) is a member of the miscellaneous antineoplastics drug class and is commonly used for Chronic Myelogenous Leukemia.
The cost for Synribo subcutaneous powder for injection 3.5 mg is around $1,170 for a supply of 1 powder for injection, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Synribo is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Synribo availability.
This Synribo price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Subcutaneous Powder For Injection
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.Print Free Discount Card
Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Synribo Coupons and Rebates
Synribo offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
There are currently no Manufacturer Promotions that we know about for this drug.
Patient Assistance Programs for Synribo
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: CORE ProgramElligibility requirements:
- Contact program for details.
- Not disclosed
- Not required
- The patient must also be residing in the US.
- Teva offers Comprehensive Oncology Reimbursement Expertise (CORE) to patients, their caregivers, and healthcare professionals. CORE offers assistance and resources to help patients better understand reimbursement eligibility. Contact program for details.
- Synribo (omacetaxine mepesuccinate) Injection; Subcutaneous
More information please phone: 888-587-3263 Visit Website
More about Synribo (omacetaxine)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- En Español
- Drug class: miscellaneous antineoplastics
- FDA Approval History